196 related articles for article (PubMed ID: 3866740)
1. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
Sekikawa K
Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
[No Abstract] [Full Text] [Related]
2. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
[TBL] [Abstract][Full Text] [Related]
3. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
[TBL] [Abstract][Full Text] [Related]
5. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
7. [CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
Bruhn HD; Broers H; Euler H; Everding A; Feller AC; Hedderich J; Jostarndt L; Jooss B; Zurborn KH; Löffler H
Dtsch Med Wochenschr; 1986 Aug; 111(34):1267-72. PubMed ID: 3461933
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of a colonic mucus antigen in normal and neoplastic gastrointestinal tissues.
Macartney JC; Oriol R; Ciclitira PJ
J Pathol; 1986 Aug; 149(4):279-85. PubMed ID: 3531447
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
[No Abstract] [Full Text] [Related]
10. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
[No Abstract] [Full Text] [Related]
11. [Colorectal neoplasms: preoperative determination of GICA].
Bussone R; Sanlorenzo M; Natta F; Rocca N; Caldarola B
Minerva Chir; 1987 Oct; 42(20):1655-6. PubMed ID: 3479706
[No Abstract] [Full Text] [Related]
12. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
Safi F; Rappenecker B; Roscher R; Beger HG
Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
[No Abstract] [Full Text] [Related]
13. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
[TBL] [Abstract][Full Text] [Related]
14. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
[TBL] [Abstract][Full Text] [Related]
15. The value of CA 19-9 in gastric and colorectal carcinoma.
Safi F; Bittner R; Roscher R; Kübel R; Beger HG
Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
[No Abstract] [Full Text] [Related]
17. [Carcinoembryonic antigen (CEA) test. A prospective clinical study of patients with gastrointestinal cancer].
Kjaer M; Fischerman K
Ugeskr Laeger; 1975 Jul; 137(31):1767-74. PubMed ID: 1154523
[No Abstract] [Full Text] [Related]
18. [Preliminary results of the clinical use of TPA (tissue polypeptide antigen)].
Dalla Pria AF; Guolo P; Piaserico PL; Ricci G; Berlanda G; Gobbi V; Minello S
Arch De Vecchi Anat Patol; 1983 Jul; 65(2-3):301-13. PubMed ID: 6680294
[No Abstract] [Full Text] [Related]
19. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
Staab HJ
Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
[No Abstract] [Full Text] [Related]
20. [Recent progress in tumor markers of the digestive system].
Mori T
Gan No Rinsho; 1983 May; 29(6):663-71. PubMed ID: 6876437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
